Spearhead Capital Advisors’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-16,876
| Closed | -$334K | – | 204 |
|
|
2021
Q4 | $334K | Buy |
16,876
+276
| +2% | +$5.46K | 0.04% | 139 |
|
|
2021
Q3 | $327K | Sell |
16,600
-92
| -0.6% | -$1.81K | 0.04% | 142 |
|
|
2021
Q2 | $367K | Buy |
16,692
+2,487
| +18% | +$54.7K | 0.05% | 157 |
|
|
2021
Q1 | $338K | Sell |
14,205
-3,643
| -20% | -$86.7K | 0.05% | 135 |
|
|
2020
Q4 | $467K | Buy |
17,848
+364
| +2% | +$9.52K | 0.07% | 103 |
|
|
2020
Q3 | $304K | Buy |
17,484
+1,147
| +7% | +$19.9K | 0.06% | 131 |
|
|
2020
Q2 | $275K | Buy |
16,337
+3,219
| +25% | +$54.2K | 0.06% | 117 |
|
|
2020
Q1 | $156K | Buy |
+13,118
| New | +$156K | 0.05% | 97 |
|